The C3-Cloud (collaborative cure and care system) is a digital infrastructure offering integrated care capability for multi-morbidity management. It enables collaboration across a number of healthcare systems and settings, allowing clinicians to semi-automatically generate a holistic personalised care plan, which offers an integrated view of the patient’s conditions, measurements, medication and goals.
The Crisis Project: Letters to the NHS was set up by first year University of Warwick Maths Student Soumya Krishna Kumar, in a bid to encourage members of the public to write bespoke letters to keyworkers, recognising them for their individual efforts during the pandemic.
In light of the highly-infectious Coronavirus pandemic, healthcare systems across the world have had to adapt rapidly for the evolving situation, which has resulted in unintentionally bringing the dawn of digital healthcare.
WMG at the University of Warwick has launched an exciting new fusion science degree, accredited by the National School of Healthcare Science as part of Health Education England, and is designed specifically to train people for a brand new, and first of its kind health role within the NHS - Digital Healthcare Scientist.
Warwick awarded £2.3 million to help develop cutting-edge technologies for cancer diagnosis and personalised treatment
Greg Clark, UK Secretary of State for Business, Energy and Industrial Strategy (BEIS), will confirm today (Tuesday 6 November) that UK Research and Innovation will invest £10 million in the PathLAKE project as part of the Industrial Strategy Challenge Fund. The University of Warwick has been awarded £2.3 million of the funding which will be used to create innovative solutions in digital pathology and Artificial Intelligence (AI) to speed up the time in which cancer is diagnosed and treated.
Using adrenaline in cardiac arrests results in less than 1% more people leaving hospital alive - but nearly doubles the survivors’ risk of severe brain damage
A clinical trial of the use of adrenaline in cardiac arrests has found that its use results in less than 1% more people leaving hospital alive - but almost doubles the risk of severe brain damage for survivors of cardiac arrest. The research raises important questions about the future use of adrenaline in such cases and will necessitate debate amongst healthcare professionals, patients and the public.